CT Urography for Upper Tract Cancer
CT urography is the main imaging test for suspected upper tract urothelial cancer (UTUC) because it evaluates the kidneys, renal pelvises, ureters and surrounding tissues in multiple contrast phases. It can show an enhancing soft-tissue mass, filling defect, urothelial thickening, hydronephrosis, enlarged lymph nodes and other signs of invasive disease. A normal CT urography does not exclude every flat or microscopic lesion, so urine cytology, cystoscopy and ureteroscopy may still be needed. The test also helps stage disease and determine whether kidney-sparing treatment or nephroureterectomy is more appropriate.
What is different about CT urography?
Unlike a routine abdominal CT, CT urography is timed to assess both renal tissue and the contrast-filled collecting systems/ureters. A non-contrast phase may identify stones or blood, while nephrographic and excretory phases assess masses and the urothelial lining.
What findings can suggest UTUC?
- Filling defect in the renal pelvis or ureter
- Focal urothelial wall thickening or enhancement
- Obstruction or hydronephrosis
- Infiltrative mass around the upper urinary tract
- Enlarged regional lymph nodes
- Evidence of disease elsewhere in the abdomen
How accurate is it?
EAU guidance describes CT urography as the most accurate available imaging technique for UTUC; pooled analyses report high sensitivity and specificity. However, flat carcinoma in situ without wall thickening or mass effect may be invisible, and very small lesions can still be missed.
What happens if CT urography is suspicious?
Cystoscopy checks the bladder. Urine cytology may support high-grade disease. Diagnostic ureteroscopy can directly inspect the lesion and obtain biopsy when imaging and cytology are insufficient for diagnosis or risk stratification.
Contrast and kidney function
Iodinated contrast is usually required for full CT urography. A recent creatinine/eGFR may be requested. When CT contrast or radiation is unsuitable, MR urography can be considered, although CT is generally more sensitive for UTUC.
The excretory phase is the reason for the test
CT urography is timed so contrast outlines the renal pelvis and ureters. A soft-tissue filling defect, focal thickening or an area that does not opacify normally can reveal an upper-tract lesion that a routine portal-venous abdominal CT may not characterise well. This is why CT KUB for stones and CT urography for urothelial cancer are not interchangeable.
Contrast planning is part of the test
Renal function, prior severe contrast reaction and the need for radiation reduction are considered before imaging. MR urography can be used in selected patients when iodinated contrast or CT radiation is unsuitable, but CT urography remains the standard high-accuracy test in most patients.
What CT urography can miss
CT urography is excellent for anatomy and many urothelial tumours, but flat carcinoma, tiny lesions and microscopic invasion may not be visible. A negative scan therefore does not automatically end evaluation when cytology is convincingly abnormal or bleeding remains unexplained. Conversely, a filling defect can represent clot or benign change. Cystoscopy, ureteroscopy, selective cytology or biopsy are used when the imaging and clinical picture do not agree.
When to seek earlier medical review
After contrast CT, urgent assessment is needed for severe allergic symptoms such as breathing difficulty or facial swelling. Persistent haematuria or positive cytology despite a “normal” CT should still be reviewed because CT urography cannot exclude every urothelial lesion.
Emergency warning signs
- Heavy bleeding or clots causing difficulty passing urine
- Fever with flank pain, chills or vomiting
- Inability to pass urine
- Severe pain or reduced urine output after a procedure
What to bring to your consultation
- CT urography images/report
- Creatinine/eGFR before contrast
- Urine cytology and cystoscopy results
- Contrast-allergy history and earlier imaging
Questions to ask your doctor
- Does the scan show a filling defect, wall thickening or invasive mass?
- Was there adequate excretory-phase opacification of the ureter?
- Why do I still need cystoscopy or ureteroscopy after this scan?
FAQs
Can CT urography distinguish low-grade from high-grade cancer?
It can show features associated with invasive/high-risk disease, but tumour grade is determined by cytology/biopsy or final pathology.
Can stones mimic a tumour?
Yes. Non-contrast and contrast phases help distinguish stones, blood clots and urothelial lesions, but ureteroscopy may be required when uncertainty remains.
Do I need cystoscopy if the CT shows a ureter tumour?
Usually yes, because bladder cancer can coexist and cystoscopy is recommended during UTUC assessment.
Is CT urography the same as CT KUB?
No. A non-contrast CT KUB is excellent for stones but does not provide the contrast/excretory information required for full urothelial tumour assessment.
Related reading
- Upper Tract Urothelial Cancer Explained
- Ureter Cancer Explained
- Renal Pelvis Cancer Explained
- Nephroureterectomy Explained
- Urologist in Latur
References
- European Association of Urology (EAU). Upper Urinary Tract Urothelial Cell Carcinoma Guidelines. Diagnosis https://uroweb.org/guidelines/upper-urinary-tract-urothelial-cell-carcinoma/chapter/diagnosis
- European Association of Urology (EAU). Upper Urinary Tract Urothelial Cell Carcinoma Guidelines. Disease Management https://uroweb.org/guidelines/upper-urinary-tract-urothelial-cell-carcinoma/chapter/disease-management
- National Cancer Institute. Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ) https://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq